TY - JOUR
T1 - Association of CRX genotypes and retinal phenotypes confounded by variable expressivity and electronegative electroretinogram
AU - Nishiguchi, Koji M.
AU - Kunikata, Hiroshi
AU - Fujita, Kosuke
AU - Hashimoto, Kazuki
AU - Koyanagi, Yoshito
AU - Akiyama, Masato
AU - Ikeda, Yasuhiro
AU - Momozawa, Yukihide
AU - Sonoda, Koh Hei
AU - Murakami, Akira
AU - Wada, Yuko
AU - Nakazawa, Toru
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Importance: A framework for understanding the phenotypic features of CRX retinopathy was established. Background: To perform a phenotype-genotype correlation analysis in two groups of patients with heterozygous mutations in distinct locations of the CRX gene, encoding the cone-rod homeobox. Design: Multicentre retrospective study. Participants: Twenty-one Japanese patients from 14 families with a heterozygous CRX mutation. Methods: Retrospective data analysis. Main Outcome Measures: Clinical records on CRX mutation, symptoms, best-corrected visual acuity (BCVA), visual field, fundus photography, fundus auto-fluorescence, optical coherence tomography and electroretinograms (ERGs). Results: Six different CRX heterozygous mutations were identified in the subjects. Twelve patients from 9 families shared the p.R41W mutation and 1 patient had the p.R43C mutation, both of which affect the homeobox domain of CRX. These patients often displayed adult-onset retinal dystrophy with macular degeneration. In contrast, five patients with downstream mutations (p.S204fs, p.S213fs, p.G243X and p.L299F) displayed retinal degeneration or macular degeneration with bone-spicule pigmentation. Three asymptomatic carriers with different mutations (p.R41W, p.S213fs and p.G243X) were present in both groups. Nearly all patients and carriers had an electronegative ERG in response to a bright flash under dark adaptation. There was no cross-sectional association between patients' age and BCVA, despite progressive decline in BCVA. Conclusions and Relevance: Heterozygous mutations within or downstream of the homeobox domain in CRX relate to the difference associated retinal phenotypes, which was confounded by variable expressivity and electronegative ERGs. CRX mutations should be considered in patients with an electronegative ERG with minimal or no macular changes.
AB - Importance: A framework for understanding the phenotypic features of CRX retinopathy was established. Background: To perform a phenotype-genotype correlation analysis in two groups of patients with heterozygous mutations in distinct locations of the CRX gene, encoding the cone-rod homeobox. Design: Multicentre retrospective study. Participants: Twenty-one Japanese patients from 14 families with a heterozygous CRX mutation. Methods: Retrospective data analysis. Main Outcome Measures: Clinical records on CRX mutation, symptoms, best-corrected visual acuity (BCVA), visual field, fundus photography, fundus auto-fluorescence, optical coherence tomography and electroretinograms (ERGs). Results: Six different CRX heterozygous mutations were identified in the subjects. Twelve patients from 9 families shared the p.R41W mutation and 1 patient had the p.R43C mutation, both of which affect the homeobox domain of CRX. These patients often displayed adult-onset retinal dystrophy with macular degeneration. In contrast, five patients with downstream mutations (p.S204fs, p.S213fs, p.G243X and p.L299F) displayed retinal degeneration or macular degeneration with bone-spicule pigmentation. Three asymptomatic carriers with different mutations (p.R41W, p.S213fs and p.G243X) were present in both groups. Nearly all patients and carriers had an electronegative ERG in response to a bright flash under dark adaptation. There was no cross-sectional association between patients' age and BCVA, despite progressive decline in BCVA. Conclusions and Relevance: Heterozygous mutations within or downstream of the homeobox domain in CRX relate to the difference associated retinal phenotypes, which was confounded by variable expressivity and electronegative ERGs. CRX mutations should be considered in patients with an electronegative ERG with minimal or no macular changes.
UR - http://www.scopus.com/inward/record.url?scp=85081543575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081543575&partnerID=8YFLogxK
U2 - 10.1111/ceo.13743
DO - 10.1111/ceo.13743
M3 - Article
C2 - 32112665
AN - SCOPUS:85081543575
SN - 1442-6404
VL - 48
SP - 644
EP - 657
JO - Australian and New Zealand Journal of Ophthalmology
JF - Australian and New Zealand Journal of Ophthalmology
IS - 5
ER -